These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23480903)

  • 1. Clinical implications of CES2 RNA expression in neuroblastoma.
    Uchida K; Otake K; Tanaka K; Hashimoto K; Saigusa S; Matsushita K; Koike Y; Inoue M; Ueeda M; Okugawa Y; Inoue Y; Mohri Y; Kusunoki M
    J Pediatr Surg; 2013 Mar; 48(3):502-9. PubMed ID: 23480903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of a human carboxylesterase 2 splice variant.
    Schiel MA; Green SL; Davis WI; Sanghani PC; Bosron WF; Sanghani SP
    J Pharmacol Exp Ther; 2007 Oct; 323(1):94-101. PubMed ID: 17636009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells.
    Xie FW; Peng YH; Chen X; Chen X; Li J; Yu ZY; Wang WW; Ouyang XN
    Biomed Pharmacother; 2014 Feb; 68(1):31-7. PubMed ID: 24439671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.
    Sanghani SP; Quinney SK; Fredenburg TB; Sun Z; Davis WI; Murry DJ; Cummings OW; Seitz DE; Bosron WF
    Clin Cancer Res; 2003 Oct; 9(13):4983-91. PubMed ID: 14581373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.
    Capello M; Lee M; Wang H; Babel I; Katz MH; Fleming JB; Maitra A; Wang H; Tian W; Taguchi A; Hanash SM
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26025324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan.
    Xu G; Zhang W; Ma MK; McLeod HL
    Clin Cancer Res; 2002 Aug; 8(8):2605-11. PubMed ID: 12171891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene.
    Bellott R; Le Morvan V; Charasson V; Laurand A; Colotte M; Zanger UM; Klein K; Smith D; Bonnet J; Robert J
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):481-8. PubMed ID: 17483951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11.
    Meck MM; Wierdl M; Wagner LM; Burger RA; Guichard SM; Krull EJ; Harris LC; Potter PM; Danks MK
    Cancer Res; 2001 Jul; 61(13):5083-9. PubMed ID: 11431345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.
    Cecchin E; Corona G; Masier S; Biason P; Cattarossi G; Frustaci S; Buonadonna A; Colussi A; Toffoli G
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6901-7. PubMed ID: 16203781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.
    Danks MK; Yoon KJ; Bush RA; Remack JS; Wierdl M; Tsurkan L; Kim SU; Garcia E; Metz MZ; Najbauer J; Potter PM; Aboody KS
    Cancer Res; 2007 Jan; 67(1):22-5. PubMed ID: 17210679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro.
    Tanimoto K; Kaneyasu M; Shimokuni T; Hiyama K; Nishiyama M
    Pharmacogenet Genomics; 2007 Jan; 17(1):1-10. PubMed ID: 17264798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.
    Pawlik CA; Iyengar RV; Krull EJ; Mason SE; Khanna R; Harris LC; Potter PM; Danks MK; Guichard SM
    Mol Ther; 2000 May; 1(5 Pt 1):457-63. PubMed ID: 10933967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship between
    Ishimine M; Lee HC; Nakaoka H; Orita H; Kobayashi T; Mizuguchi K; Endo M; Inoue I; Sato K; Yokomizo T
    Dis Markers; 2018; 2018():5280736. PubMed ID: 29651325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma.
    Otake K; Uchida K; Tanaka K; Koike Y; Inoue M; Matsushita K; Ueeda M; Hashimoto K; Kitajima T; Komada Y; Kusunoki M
    Pediatr Surg Int; 2011 Feb; 27(2):217-23. PubMed ID: 21046120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor expression is closely related to irinotecan-mediated inhibition of tumor growth and angiogenesis in neuroblastoma xenografts.
    Kaneko S; Ishibashi M; Kaneko M
    Cancer Sci; 2008 Jun; 99(6):1209-17. PubMed ID: 18384433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted and tumour targeted human carboxylesterase for activation of irinotecan.
    Oosterhoff D; Pinedo HM; van der Meulen IH; de Graaf M; Sone T; Kruyt FA; van Beusechem VW; Haisma HJ; Gerritsen WR
    Br J Cancer; 2002 Sep; 87(6):659-64. PubMed ID: 12237777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan.
    Calvet L; Geoerger B; Regairaz M; Opolon P; Machet L; Morizet J; Joseph JM; Elie N; Vassal G
    Oncogene; 2006 May; 25(22):3150-9. PubMed ID: 16501609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.
    Sanghani SP; Quinney SK; Fredenburg TB; Davis WI; Murry DJ; Bosron WF
    Drug Metab Dispos; 2004 May; 32(5):505-11. PubMed ID: 15100172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11).
    Matzow T; Cowen RL; Williams KJ; Telfer BA; Flint PJ; Southgate TD; Saunders MP
    J Gene Med; 2007 Apr; 9(4):244-52. PubMed ID: 17397102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotypes and a novel defective allele of CES2 found in a Japanese population.
    Kim SR; Sai K; Tanaka-Kagawa T; Jinno H; Ozawa S; Kaniwa N; Saito Y; Akasawa A; Matsumoto K; Saito H; Kamatani N; Shirao K; Yamamoto N; Yoshida T; Minami H; Ohtsu A; Saijo N; Sawada J
    Drug Metab Dispos; 2007 Oct; 35(10):1865-72. PubMed ID: 17640957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.